Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer

Class:IdLiteratureReference:2008166
_displayNameEGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer
_timestamp2011-11-21 21:22:30
author[Person:1181012] Choi, SH
[Person:2008150] Mendrola, JM
[Person:179814] Lemmon, MA
created[InstanceEdit:2008164] Orlic-Milacic, Marija, 2011-11-21
journalOncogene
modified[InstanceEdit:2008168] Orlic-Milacic, Marija, 2011-11-21
pages1567-76
pubMedIdentifier16953218
titleEGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer
volume26
year2007
(literatureReference)[Reaction:1225949] Binding of CBL to ligand-responsive p-6Y-EGFR mutants [Homo sapiens]
[Reaction:1225950] Binding of GRB2:SOS1 complex to phosphorylated ligand-responsive EGFR mutants [Homo sapiens]
[Reaction:1226016] Binding of GRB2:GAB1 complex to ligand-responsive p-6Y-EGFR mutants [Homo sapiens]
[Reaction:1247841] PLCG1 binds to ligand-responsive p-6Y-EGFR mutants [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer (2008166)